BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11331150)

  • 1. Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?
    Frank GK; Kaye WH; Sahu A; Fernstrom J; McConaha C
    Neuropsychopharmacology; 2001 Jun; 24(6):706-9. PubMed ID: 11331150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
    Frank GK; Kaye WH; Ladenheim EE; McConaha C
    Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered dopamine activity after recovery from restricting-type anorexia nervosa.
    Kaye WH; Frank GK; McConaha C
    Neuropsychopharmacology; 1999 Oct; 21(4):503-6. PubMed ID: 10481833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.
    Mantzoros C; Flier JS; Lesem MD; Brewerton TD; Jimerson DC
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1845-51. PubMed ID: 9177394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.
    Frank GK; Kaye WH; Altemus M; Greeno CG
    Biol Psychiatry; 2000 Aug; 48(4):315-8. PubMed ID: 10960163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional disturbances of the hypothalamus in patients with anorexia nervosa].
    Pałasz A
    Psychiatr Pol; 2004; 38(6):1001-9. PubMed ID: 15779664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease.
    Berrettini WH; Kaye WH; Sunderland T; May C; Gwirtsman HE; Mellow A; Albright A
    Neuropsychobiology; 1988; 19(2):64-8. PubMed ID: 2465504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA; Lesem MD; Listwak SJ; Brandt HA; Jimerson DC; Gold PW
    Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid opioid activity in anorexia nervosa.
    Kaye WH; Pickar D; Naber D; Ebert MH
    Am J Psychiatry; 1982 May; 139(5):643-5. PubMed ID: 7072853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa.
    Wagner A; Greer P; Bailer UF; Frank GK; Henry SE; Putnam K; Meltzer CC; Ziolko SK; Hoge J; McConaha C; Kaye WH
    Biol Psychiatry; 2006 Feb; 59(3):291-3. PubMed ID: 16139807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
    Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
    Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
    Kaye WH; Berrettini W; Gwirtsman H; George DT
    Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexia nervosa, obsessional behavior, and serotonin.
    Kaye WH
    Psychopharmacol Bull; 1997; 33(3):335-44. PubMed ID: 9550876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.
    Kaye WH; Weltzin TE
    J Clin Psychiatry; 1991 Dec; 52 Suppl():41-8. PubMed ID: 1752859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
    Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
    Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight.
    Leibowitz SF
    Ann N Y Acad Sci; 1998 Dec; 863():206-20. PubMed ID: 9928172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y facilitates activity-based-anorexia.
    Nergårdh R; Ammar A; Brodin U; Bergström J; Scheurink A; Södersten P
    Psychoneuroendocrinology; 2007 Jun; 32(5):493-502. PubMed ID: 17467917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects.
    Gerner RH; Wilkins JN
    Am J Psychiatry; 1983 Jan; 140(1):92-4. PubMed ID: 6183982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review.
    Tortorella A; Brambilla F; Fabrazzo M; Volpe U; Monteleone AM; Mastromo D; Monteleone P
    Eur Eat Disord Rev; 2014 Sep; 22(5):307-20. PubMed ID: 24942507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa.
    Lesem MD; Kaye WH; Bissette G; Jimerson DC; Nemeroff CB
    Biol Psychiatry; 1994 Jan; 35(1):48-53. PubMed ID: 8167204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.